We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
10 Year Est. Return
AUM
$105M
AUM Growth
+$9.57M
Cap. Flow
+$7.18M
Cap. Flow %
6.85%
Top 10 Hldgs %
21.25%
Holding
64
New
2
Increased
53
Reduced
7
Closed
2

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$2.23M
2
ADP icon
Automatic Data Processing
ADP
+$2.14M
3
CAH icon
Cardinal Health
CAH
+$193K
4
GD icon
General Dynamics
GD
+$142K
5
ABBV icon
AbbVie
ABBV
+$135K

Sector Composition

Rank Sector Weight
1 Financials 21.5%
2 Healthcare 14.65%
3 Industrials 12.71%
4 Technology 11.77%
5 Energy 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
51
Verizon
VZ
$183B
$1.26M 1.2%
25,152
+1,451
+6% +$67.2K
LYB icon
52
LyondellBasell Industries
LYB
$19.6B
$1.2M 1.15%
14,921
+825
+6% +$48.9K
UPS icon
53
United Parcel Service
UPS
$96.2B
$1.15M 1.1%
11,716
+672
+6% +$72.1K
KMB icon
54
Kimberly-Clark
KMB
$36B
$1.15M 1.1%
11,914
+719
+6% +$73.6K
BMY icon
55
Bristol-Myers Squibb
BMY
$124B
$1.14M 1.08%
18,758
-619
-3% -$36.1K
CAH icon
56
Cardinal Health
CAH
$52.9B
$1.03M 0.98%
4,876
+897
+23% +$193K
BEN icon
57
Franklin Resources
BEN
$16.7B
$979K 0.93%
41,347
+2,605
+7% +$67K
GPC icon
58
Genuine Parts
GPC
$16.8B
$953K 0.91%
9,011
+523
+6% +$64.7K
EMN icon
59
Eastman Chemical
EMN
$7.78B
$908K 0.87%
11,897
+659
+6% +$47.5K
BBY icon
60
Best Buy
BBY
$18B
$844K 0.81%
13,157
+735
+6% +$48.3K
MDT icon
61
Medtronic
MDT
$107B
$622K 0.59%
7,176
+1,314
+22% +$126K
TROW icon
62
T. Rowe Price
TROW
$25B
$598K 0.57%
6,631
+368
+6% +$35.7K
ARE icon
63
Alexandria Real Estate Equities
ARE
$8.72B
-21,534
Closed -$1.05M
TFC icon
64
Truist Financial
TFC
$62.3B
-18,822
Closed -$927K

Similar funds

Weaver C. Barksdale & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Weaver C. Barksdale & Associates held 64 positions worth $105M, up 10% from $95.3M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Weaver C. Barksdale & Associates deployed $7.18M of net new capital in Q1 2026, opening 2 new positions and adding to 53 existing holdings. Its largest new stake was Accenture: 9,590 shares worth $1.9M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Lockheed Martin, an estimated $304K trimmed.

  • Weaver C. Barksdale & Associates's largest Q1 2026 buy was Accenture: 9,590 shares worth $1.9M.
  • Weaver C. Barksdale & Associates added most to Cardinal Health in Q1 2026, an estimated $193K increase.
  • Weaver C. Barksdale & Associates's biggest Q1 2026 reduction was Lockheed Martin, cutting an estimated $304K.
  • Weaver C. Barksdale & Associates fully exited Alexandria Real Estate Equities in Q1 2026, selling an estimated $1.05M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 21% of its $105M portfolio in Q1 2026.
  • Weaver C. Barksdale & Associates opened 2 new positions and closed 2 in Q1 2026.
  • Weaver C. Barksdale & Associates's portfolio value rose 10% quarter-over-quarter to $105M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2026, filed 14 May 2026.